Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases

被引:12
|
作者
Mostafa, Mahmoud [1 ]
Al Fatease, Adel [2 ]
Alany, Raid G. [3 ,4 ]
Abdelkader, Hamdy [2 ]
机构
[1] Minia Univ, Fac Pharm, Dept Pharmaceut, Al Minya 61519, Egypt
[2] King Khalid Univ, Coll Pharm, Dept Pharmaceut, Abha 62223, Saudi Arabia
[3] Kingston Univ London, Sch Pharm, Kingston Upon Tames KT1 2EE, England
[4] Univ Auckland, Sch Pharm, Auckland 1010, New Zealand
关键词
chronic eye diseases; inserts; implants; ocular delivery; IN-VITRO CHARACTERIZATION; VIVO PHARMACODYNAMIC EVALUATION; NANOSTRUCTURED LIPID CARRIERS; DRY-EYE; SUSTAINED-RELEASE; EX-VIVO; MACULAR DEGENERATION; OPHTHALMIC DELIVERY; HYALURONIC-ACID; AQUEOUS-HUMOR;
D O I
10.3390/pharmaceutics15061746
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic ocular diseases can seriously impact the eyes and could potentially result in blindness or serious vision loss. According to the most recent data from the WHO, there are more than 2 billion visually impaired people in the world. Therefore, it is pivotal to develop more sophisticated, long-acting drug delivery systems/devices to treat chronic eye conditions. This review covers several drug delivery nanocarriers that can control chronic eye disorders non-invasively. However, most of the developed nanocarriers are still in preclinical or clinical stages. Long-acting drug delivery systems, such as inserts and implants, constitute the majority of the clinically used methods for the treatment of chronic eye diseases due to their steady state release, persistent therapeutic activity, and ability to bypass most ocular barriers. However, implants are considered invasive drug delivery technologies, especially those that are nonbiodegradable. Furthermore, in vitro characterization approaches, although useful, are limited in mimicking or truly representing the in vivo environment. This review focuses on long-acting drug delivery systems (LADDS), particularly implantable drug delivery systems (IDDS), their formulation, methods of characterization, and clinical application for the treatment of eye diseases.
引用
收藏
页数:50
相关论文
共 50 条
  • [31] Advances in the diagnosis and therapy for diseases of the ocular surface: Dry eye and ocular allergies
    Messmer, E. M.
    Benitez del Castello, J.
    Lambiase, A.
    Doan, S.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2006, 223 (08) : 643 - 649
  • [32] Ocular drug delivery-eye on innovation
    Rupenthal, Ilva D.
    O'Rourke, Michael
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2016, 6 (06) : 631 - 633
  • [33] Recent advances in nanocrystal-based technologies applied for ocular drug delivery
    Geng, Feiyang
    Fan, Xingyan
    Liu, Yu
    Lu, Weiyue
    Wei, Gang
    EXPERT OPINION ON DRUG DELIVERY, 2024, 21 (02) : 211 - 227
  • [34] Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers
    Sah, Abhishek K.
    Suresh, Preeti K.
    RECENT PATENTS ON NANOTECHNOLOGY, 2015, 9 (02) : 94 - 105
  • [35] Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses
    Pelusi, Letizia
    Mandatori, Domitilla
    Mastropasqua, Leonardo
    Agnifili, Luca
    Allegretti, Marcello
    Nubile, Mario
    Pandolfi, Assunta
    PHARMACEUTICS, 2023, 15 (02)
  • [36] Microemulsions as ocular drug delivery systems: recent developments and future challenges
    Vandamme, TF
    PROGRESS IN RETINAL AND EYE RESEARCH, 2002, 21 (01) : 15 - 34
  • [37] OCULAR DRUG DELIVERY SYSTEMS: A REVIEW
    Macovei, Laura
    Gheorghe, Alina
    Schmitzer, Speranta
    Burcea, Marian
    Morosanu, Matei
    FARMACIA, 2021, 69 (06) : 1018 - 1031
  • [38] Drug delivery in ocular diseases: Barriers and strategies
    Deep Kwatra
    Ashim K Mitra
    World Journal of Pharmacology, 2013, 2 (04) : 78 - 83
  • [39] Nanoparticles in Ocular Drug Delivery Systems
    Almeida, Hugo
    Silva, Ana Catarina
    PHARMACEUTICS, 2023, 15 (06)
  • [40] OCULAR DRUG DELIVERY SYSTEMS - A REVIEW
    SHELL, JW
    JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY, 1982, 1 (01): : 49 - 63